A. Bary

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial

H. Rahimi, H. Rafatpanah, A. Allahyari, 2020, Trials.

Investigation of hematological parameters related to the severity of COVID-19 disease in Mashhad, Iran

H. Rahimi, A. Allahyari, M. Nodeh, 2020, Immunopathologia Persa.

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

S. Najafi, S. Razavi, Sina Salari, 2022, BMC Cancer.

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial

H. Rahimi, A. Allahyari, Majid Khadem-Rezaiyan, 2021, Trials.

Combination therapy and survival time in Adult T cell Leukemia/Lymphoma (ATLL)

Hanieh Tarokhian, H. Rahimi, A. Shirdel, 2019 .

Modifications in Breast Cancer Guidelines in COVID-19 Pandemic; An Iranian Consensus

F. Shahi, A. Kaviani, M. Aghili, 2020 .